Donald Olds

NEOMED is a not-for-profit organization pioneering a new approach to drug development as a public-private partnership with government and biopharmaceutical companies. NEOMED is a response to the changing pharma R&D business model: in view of the considerable gap between basic research and later-stage drug development, we seek to create abridge. We provide expertise and funding for academic labs and early biotechs, assisting them in bringing emerging therapeutic approaches to the stage of human proof of concept; at which point these de-risked projects will have gained significant value for NEOMED’s downstream partners.